Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer

References

• Adiseshaiah PP, Crist RM, Hook SS, McNeil SE. (2016). Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nat Rev Clin Oncol 13:1712–65.
   Web of Science ®Google Scholar
• Adlravan E, Nejati K, Karimi MA, et al. (2021). Potential activity of free and PLGA/PEG nanoencapsulated Nasturtium officinale extract in inducing cytotoxicity and apoptosis in human lung carcinoma A549 cells. J Drug Deliv Sci Technol 61:102256.
   Web of Science ®Google Scholar
• Ahmed A, Tait S. (2020). Targeting immunogenic cell death in cancer. Mol Oncol 14:2994–3006.
   PubMed Web of Science ®Google Scholar
• Allahyari M, Mohit E. (2016). Peptide/protein vaccine delivery system based on PLGA particles. Hum Vaccin Immunother 12:806–28.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. (2018). Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–75.
   PubMed Web of Science ®Google Scholar
• Auberger P, Tamburini-Bonnefoy J, Puissant A. (2020). Drug resistance in hematological malignancies. Int J Mol Sci 21:6091.
   PubMed Web of Science ®Google Scholar
• Bent EH, Millan-Barea LR, Zhuang I, et al. (2021). Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy. Nat Commun 12:6218.
   PubMed Web of Science ®Google Scholar
• Chen C, Ni X, Jia S, et al. (2019). Massively evoking immunogenic cell death by focused mitochondrial oxidative stress using an AIE luminogen with a twisted molecular structure. Adv Mater 31:e1904914.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liang Y, Feng X, et al. (2021). Vitamin-B12-conjugated PLGA-PEG nanoparticles incorporating miR-532-3p induce mitochondrial damage by targeting apoptosis repressor with caspase recruitment domain (ARC) on CD320-overexpressed gastric cancer. Mater Sci Eng C Mater Biol Appl 120:111722.
   PubMed Web of Science ®Google Scholar
• Cruz E, Kayser V. (2019). Synthesis and enhanced cellular uptake in vitro of Anti-HER2 multifunctional gold nanoparticles. Cancers (Basel) 11:870.
   PubMed Web of Science ®Google Scholar
• Duan H, Liu Y, Gao Z, Huang W. (2021). Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharm Sin B 11:55–70.
   PubMed Web of Science ®Google Scholar
• Duan X, Chan C, Lin W. (2019). Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy. Angew Chem Int Ed Engl 58:670–80.
   PubMed Web of Science ®Google Scholar
• Eastman AJ, Xu J, Bermik J, et al. (2019). Epigenetic stabilization of DC and DC precursor classical activation by TNFalpha contributes to protective T cell polarization. Sci Adv 5:w9051.
   Web of Science ®Google Scholar
• Faramarzi L, Dadashpour M, Sadeghzadeh H, et al. (2019). Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells. Artif Cells Nanomed Biotechnol 47:737–46.
   PubMed Web of Science ®Google Scholar
• Fasehee H, Dinarvand R, Ghavamzadeh A, et al. (2016). Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: In vitro and in vivo investigations. J Nanobiotechnology 14:32.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Warren S, et al. (2020). Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer 8:e000337.
   PubMed Web of Science ®Google Scholar
• Guo W, Chen Z, Chen J, et al. (2020). Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer. J Nanobiotechnology 18:99.
   PubMed Web of Science ®Google Scholar
• Han LY, Wu YL, Zhu CY, et al. (2019). Improved pharmacokinetics of icariin (ICA) within formulation of PEG-PLLA/PDLA-PNIPAM polymeric micelles. Pharmaceutics 11:51.
   PubMed Web of Science ®Google Scholar
• Hou J, Zhao R, Xia W, et al. (2020). PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol 22:1264–75.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang X, Cao H, et al. (2018). A bone-targeting delivery system carrying osteogenic phytomolecule icaritin prevents osteoporosis in mice. Biomaterials 182:58–71.
   PubMed Web of Science ®Google Scholar
• Ippolito L, Giannoni E, Chiarugi P, Parri M. (2020). Mitochondrial redox hubs as promising targets for anticancer therapy. Front Oncol 10:256.
   PubMed Web of Science ®Google Scholar
• Jewett A, Kos J, Kaur K, et al. (2020). Natural killer cells: diverse functions in tumor immunity and defects in pre-neoplastic and neoplastic stages of tumorigenesis. Mol Ther Oncolytics 16:41–52.
   PubMed Web of Science ®Google Scholar
• Jin L, Miao J, Liu Y, et al. (2017). Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells. Biomed Pharmacother 85:287–95.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. (2013). Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72.
   PubMed Web of Science ®Google Scholar
• Li C, Brazill JM, Liu S, et al. (2017). Spermine synthase deficiency causes lysosomal dysfunction and oxidative stress in models of Snyder-Robinson syndrome. Nat Commun 8:1257.
   PubMed Web of Science ®Google Scholar
• Li H, Ham A, Ma TC, et al. (2019). Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations. Autophagy 15:113–30.
   PubMed Web of Science ®Google Scholar
• Li J, Gao H, Liu R, et al. (2020). Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death. Sci China Chem 63:1428–34.
   Web of Science ®Google Scholar
• Li X, Jiang X. (2018). Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles. Adv Drug Deliv Rev 128:101–14.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang M, Deng Z, et al. (2021). Low dose soft X-Ray remotely triggered lanthanide nanovaccine for deep tissue CO gas release and activation of systemic Anti-Tumor immunoresponse. Adv Sci (Weinh) 8:e2004391.
   PubMedGoogle Scholar
• Liu Y, Xu Y, Zhang Z, et al. (2019). A simple, yet multifunctional, nanoformulation for eradicating tumors and preventing recurrence with safely low administration dose. Nano Lett 19:5515–23.
   PubMed Web of Science ®Google Scholar
• Luo H, Vong CT, Chen H, et al. (2019). Naturally occurring anti-cancer compounds: Shining from Chinese herbal medicine. Chin Med 14:48.
   PubMed Web of Science ®Google Scholar
• Lv M, Zhang M, Cheng Y, et al. (2017). Renoprotective effects of total glucosides from paeony against nephrotoxicity induced by total alkaloids from semen strychni. Evid Based Complement Alternat Med 2017:1–9.
   Web of Science ®Google Scholar
• Lv Y, Li T, Yang M, et al. (2021). Melatonin attenuates chromium (VI)-Induced spermatogonial stem Cell/Progenitor mitophagy by restoration of METTL3-Mediated RNA N6-Methyladenosine Modification. Front Cell Dev Biol 9:684398.
   PubMed Web of Science ®Google Scholar
• Martin-Fernandez B, Gredilla R. (2018). Mitochondrial oxidative stress and cardiac ageing. Clin Investig Arterioscler 30:74–83.
   PubMed Web of Science ®Google Scholar
• Montemurro L, Raieli S, Angelucci S, et al. (2019). A novel MYCN-Specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-Amplified neuroblastoma. Cancer Res 79:6166–77.
   PubMed Web of Science ®Google Scholar
• Oresta B, Pozzi C, Braga D, et al. (2021). Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer. Sci Transl Med 13:eaba6110.
   PubMed Web of Science ®Google Scholar
• Qin SK, Li Q, Ming XJ, et al. (2020). Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: immunodynamic biomarkers and overall survival. Cancer Sci 111:4218–31.
   PubMed Web of Science ®Google Scholar
• Qiu X, Qu Y, Guo B, et al. (2022). Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer. J Control Release 341:498–510.
   PubMed Web of Science ®Google Scholar
• Salas-Benito D, Perez-Gracia JL, Ponz-Sarvise M, et al. (2021). Paradigms on immunotherapy combinations with chemotherapy. Cancer Discov 11:1353–67.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Nilsson M, Grabsch HI, et al. (2020). Gastric cancer. Lancet 396:635–48.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 71:209–49.
   PubMed Web of Science ®Google Scholar
• Tabatabaei MF, Akbarzadeh A, Milani M, et al. (2016). A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol 44:423–30.
   PubMed Web of Science ®Google Scholar
• Tao H, Liu M, Wang Y, et al. (2021). Icaritin induces anti-tumor immune responses in hepatocellular carcinoma by inhibiting splenic Myeloid-Derived suppressor cell generation. Front Immunol 12:609295.
   PubMed Web of Science ®Google Scholar
• Vasan N, Baselga J, Hyman DM. (2019). A view on drug resistance in cancer. Nature 575:299–309.
   PubMed Web of Science ®Google Scholar
• Wang Q, Ju X, Wang J, et al. (2018). Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies. Cancer Lett 438:17–23.
   PubMed Web of Science ®Google Scholar
• Wei Q, Wang B, Hu H, et al. (2020). Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression. Int J Mol Med 45:816–24.
   PubMed Web of Science ®Google Scholar
• Wu T, Shu T, Kang L, et al. (2017). Icaritin, a novel plant-derived osteoinductive agent, enhances the osteogenic differentiation of human bone marrow- and human adipose tissue-derived mesenchymal stem cells. Int J Mol Med 39:984–92.
   PubMed Web of Science ®Google Scholar
• Wu T, Wang S, Wu J, et al. (2015). Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma. J Exp Clin Cancer Res 34:17.
   PubMed Web of Science ®Google Scholar
• Wu X, Long X, Yang C, et al. (2020). Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model. J Cancer 11:6556–64.
   PubMed Web of Science ®Google Scholar
• Xue T. (2016). Synergy in traditional Chinese medicine. Lancet Oncol 17:e39.
   PubMed Web of Science ®Google Scholar
• Yu Z, Guo J, Hu M, et al. (2020). Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma. Acs Nano 14:4816–28.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qiu N, Zhang Y, et al. (2021). Oxygen-carrying nanoparticle-based chemo-sonodynamic therapy for tumor suppression and autoimmunity activation. Biomater Sci 9:3989–4004.
   PubMed Web of Science ®Google Scholar
• Zhao X, Lin Y, Jiang B, et al. (2020). Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK/mTOR signaling pathway. Anticancer Drugs 31:1004–11.
   PubMed Web of Science ®Google Scholar
• Zheng N, Liu W, Li B, et al. (2019). Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib. J Exp Clin Cancer Res 38:232.
   PubMed Web of Science ®Google Scholar